BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, August 3, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Francis Collins, director, U.S. NIH

Collins temporarily assigned new scientific role in US government

Feb. 17, 2022
By Mari Serebrov
As the Biden administration continues to play musical chairs with key U.S. federal health leadership positions, its latest move is naming Francis Collins to serve as science adviser to the president and co-chair of the President’s Council of Advisers on Science and Technology.
Read More

Regulatory actions for Feb. 17, 2022

Feb. 17, 2022
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acadia, Avenue, Biontech, Celcuity, GBT, Hemogenyx, Hillstream, Jixing, Lexeo, Mirati, Moderna, Pfizer, Revive, Sirnaomics, Swanbio.
Read More

Other news to note for Feb. 17, 2022

Feb. 17, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Applied DNA Sciences, Aridis, Biontech, Catalyst, Davita Clinical Research, Enveric, Evvivax, Insilico Medicine, Intervivo Solutions, Johnson & Johnson, Mediwound, Mindset, Neopharm, Neumora, Partner, Pfizer, Quoin, Repertoire, Shanghai Fosun, Yumanity.
Read More

Other news to note for Feb. 16, 2022

Feb. 16, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bioniz, Biontech, Biovaxys Technology, Cambrian, Endoceutics, Equillium, Gilead, GMSA, Helsinn, Hookipa, Horizon, Mydecine Innovations, Nova Mentis, Novelty Nobility, Novartis, Recbio, Shionogi, Skye, Telix, Tetra, Theramex, Trestle, Valenzabio, Verity.
Read More

In the clinic for Feb. 16, 2022

Feb. 16, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Amgen, Axial, Bionet, Calliditas, Cerevel, Cytokinetics, Enanta, Horizon, Inflarx, JCR, Monopar, Nrx, PDS, Pharmajet, Promore, Rakuten, Spero, Stealth, Technovalia, Zielbio.


Read More
COVID-19 research illustration

Worldwide, there’s a long line of long COVID studies

Feb. 15, 2022
By Lee Landenberger
More than 100 million people worldwide are thought to have post-acute COVID-19 syndrome, roughly 40% of everyone on the planet who’s had COVID. Now, thousands of them are beginning to cycle through clinical and preclinical studies designed to get a better look at this little understood aspect of the pandemic.
Read More
Nonprofit stamp

Nonprofit deal and grant activity focused on pandemic falls by 68%

Feb. 15, 2022
By Karen Carey
The number of biopharma deals with nonprofits or government entities has dropped over last year, partly due to fewer COVID-19-related alliances, but the activity in 2022 is still strong in comparison to pre-pandemic years.
Read More

Regulatory actions for Feb. 15, 2022

Feb. 15, 2022
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascletis, Axcella, Avion, Bavarian Nordic, Cidara.
Read More

In the clinic for Feb. 15, 2022

Feb. 15, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Laurent, Statera, Xbrane, Zealand.


Read More
COVID-19 research illustration

Studies at CROI show interferons' complex effects, therapeutic potential

Feb. 15, 2022
By Anette Breindl
It's neither a retrovirus nor an opportunistic infection. But of course, SARS-CoV-2 has a prominent place at the table at the 2022 Conference on Retroviruses and Opportunistic Infections (CROI) – starting with the fact that COVID-19 has again forced the conference to go virtual.
Read More
Previous 1 2 … 133 134 135 136 137 138 139 140 141 … 553 554 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 31, 2026.
  • Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

    BioWorld Science
    Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
  • Silhouette illustration of DNA gene editing

    Death in Chinese gene-editing trial exposes ethical fault lines

    BioWorld
    The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
  • Mitochondria

    Seed funding at Adjuvia to treat mitochondrial dysfunction

    BioWorld Science
    Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
  • Skin through magnifier

    Replimune’s RP-1 for melanoma wins over FDA adcom

    BioWorld
    Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing